International study finds insomnia, anxiety and depression very prevalent during first phase of COVID-19 pandemic
10 September 2021
Researchers are recommending public health interventions to reduce the long-term adverse outcomes associated with chronic insomnia and mental health problems.
13 August 2020
Changes in the way that neurons communicate with each other affect our ability to move between sleep and wake states.
27 July 2020
Professor Robert MacLaren is the winner of the Inspiring Leadership category in the Vice-Chancellor's Innovation Awards 2020 for his work on Nightstar, a retinal gene therapy company.
22 July 2020
DPhil student Lampros Bisdounis summarises a departmental seminar by Associate Professor Simon Kyle
11 June 2020
An international group of researchers led by Professor Colin Espie is investigating the impact of the COVID-19 pandemic on sleep and daily rhythms in adults.
16 May 2020
On the UNESCO International Day of Light, The Daylight Award announce the 2020 Laureates, including Russell Foster who receives the award for his clinical studies in humans addressing important questions regarding light.
6 April 2020
NHS England has announced a programme to provide NHS staff with evidence-based digital programmes to protect their mental health during the COVID-19 response. The apps are designed to help maintain healthy sleep, and reduce anxiety.
27 February 2020
The results of a first-in-human clinical trial of gene therapy to treat a common cause of genetic blindness have shown partial reversal of sight loss in some patients.
18 February 2020
£277,000 from the estate of Jean Williams will support cutting-edge studies into macular disease, which affects nearly 1.5 million people.
10 October 2019
Dr Kanmin Xue has won the Ruskell Medal from the Worshipful Company of Spectacle Makers
16 May 2019
The Oxford BRC is delighted to announce the appointment of seven new Senior Research Fellows.
21 March 2019
Researchers in our Sleep and Circadian Neuroscience Institute are working with Havant & South Downs College on a teenage sleep study.
19 February 2019
Researchers in Oxford have carried out the world’s first gene therapy operation to tackle the root cause of age-related macular degeneration (AMD), the UK’s most common cause of sight loss.